Overall, adverse events occurring most frequently included dermatologic symptoms (52.2% of patients), gastrointestinal symptoms (13.2% of patients), neurological and psychiatric manifestations (8.8% of patients), symptoms of hepatotoxicity (7, 4%), and cochlear vestibular symptoms (6.6% of patients).